About 283,000 results
Open links in new tab
  1. Pfizer Completes Acquisition of Trillium Therapeutics

    Nov 17, 2021 · Acquisition enhances Pfizer’s Oncology portfolio with addition of next-generation, investigational immuno-therapeutics for hematological malignancies Pfizer Inc. (NYSE: PFE) …

  2. Trillium Therapeutics Inc. - LinkedIn

    Trillium Therapeutics Inc. (NASDAQ/TSX:TRIL) is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. We have a strong focus on CD47, …

  3. Pfizer to buy Canadian drug developer Trillium Therapeutics ... - CBC.ca

    Aug 23, 2021 · Pfizer Inc. said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc. in a $2.26 billion deal to strengthen its arsenal of blood cancer therapies. …

  4. Trillium Therapeutics - PitchBook

    Trillium Therapeutics General Information Description. Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer.

  5. UPDATE: Pfizer and Trillium: How a $25M investment led to a …

    Sep 14, 2021 · The relationship continued to progress, with Settleman providing his advice on the board. In the early summer of 2021, Trillium President and CEO Jan Skvarka began pressing …

  6. Pfizer to Acquire Trillium Therapeutics Inc. - Business Wire

    Aug 23, 2021 · NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual 2025 Annual Meeting of …

  7. Trillium Therapeutics - Crunchbase Company Profile & Funding

    Contact Email [email protected]; Phone Number 416-595-0627; Trillium Therapeutics Inc. operates as a biopharmaceutical research and development company. It focuses on the …

  8. Pfizer acquires immuno-oncology firm Trillium for $2.22bn

    Nov 18, 2021 · The Trillium takeover will enhance Pfizer’s oncology portfolio. Credit: Montgomery County Planning Commission / Flickr. Pfizer has concluded the acquisition of all outstanding …

  9. Trillium Therapeutics Inc · 2488 Dunwin Dr, Mississauga, L5L 1J9

    The business information was updated on December 12, 2019. The registered business location is at 2488 Dunwin Dr, Mississauga, L5L 1J9, with contact phone number 416-595-0627. The …

  10. Pfizer to Acquire Trillium Therapeutics Inc.

    Aug 23, 2021 · Proposed acquisition strengthens Pfizer’s category leadership in Oncology with addition of next-generation, investigational immuno-therapeutics for hematological …

Refresh